STOCK TITAN

DIH Announces Closing of $4.6 Million Public Offering

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

DIH Holding US (NASDAQ: DHAI) has successfully closed its previously announced public offering, raising $4.6 million in gross proceeds. The offering consisted of 5,937,100 units priced at $0.7832 per unit, with each unit comprising one share of Class A common stock and one Class A warrant. The warrants are immediately exercisable at $0.7832 per share and will expire after five years.

Maxim Group served as the sole placement agent for the offering. The company plans to utilize the net proceeds for capital expenditures, working capital, and general corporate purposes. The offering was conducted pursuant to a registration statement on Form S-1 that was declared effective by the SEC on January 31, 2025.

DIH Holding US (NASDAQ: DHAI) ha concluso con successo l'offerta pubblica precedentemente annunciata, raccogliendo 4,6 milioni di dollari in proventi lordi. L'offerta consisteva in 5.937.100 unità al prezzo di 0,7832 dollari per unità, con ogni unità composta da una azione di Classe A e un warrant di Classe A. I warrant sono immediatamente esercitabili a 0,7832 dollari per azione e scadranno dopo cinque anni.

Maxim Group ha funto da unico agente di collocamento per l'offerta. L'azienda intende utilizzare i proventi netti per spese in conto capitale, capitale circolante e scopi aziendali generali. L'offerta è stata condotta ai sensi di una dichiarazione di registrazione sul modulo S-1 che è stata dichiarata efficace dalla SEC il 31 gennaio 2025.

DIH Holding US (NASDAQ: DHAI) ha cerrado con éxito su oferta pública previamente anunciada, recaudando 4,6 millones de dólares en ingresos brutos. La oferta consistió en 5.937.100 unidades a un precio de 0,7832 dólares por unidad, donde cada unidad comprende una acción de Clase A y una garantía de Clase A. Las garantías son ejercitables de inmediato a 0,7832 dólares por acción y expiran después de cinco años.

Maxim Group actuó como el único agente de colocación para la oferta. La empresa planea utilizar los ingresos netos para gastos de capital, capital de trabajo y fines corporativos generales. La oferta se llevó a cabo de acuerdo con una declaración de registro en el Formulario S-1 que fue declarada efectiva por la SEC el 31 de enero de 2025.

DIH Holding US (NASDAQ: DHAI)는 이전에 발표한 공모를 성공적으로 마감하였으며, 460만 달러의 총 수익을 올렸습니다. 이 공모는 5,937,100개 단위로 구성되어 있으며, 각 단위는 단위당 0.7832달러의 가격으로 제공됩니다. 각 단위에는 A 클래스 일반 주식 1주와 A 클래스 워런트 1개가 포함되어 있습니다. 워런트는 주당 0.7832달러에 즉시 행사 가능하며, 5년 후에 만료됩니다.

Maxim Group은 이 공모의 유일한 배치 에이전트로 활동했습니다. 회사는 순수익을 자본 지출, 운전 자본 및 일반 기업 목적에 사용할 계획입니다. 이 공모는 SEC에 의해 2025년 1월 31일에 유효하다고 선언된 S-1 양식에 따른 등록 진술서에 따라 진행되었습니다.

DIH Holding US (NASDAQ: DHAI) a réussi à finaliser son offre publique précédemment annoncée, levant 4,6 millions de dollars de produits bruts. L'offre était constituée de 5.937.100 unités au prix de 0,7832 dollar par unité, chaque unité comprenant une action ordinaire de Classe A et un bon de souscription de Classe A. Les bons de souscription peuvent être exercés immédiatement à 0,7832 dollar par action et expireront après cinq ans.

Maxim Group a été l'agent de placement exclusif pour l'offre. La société prévoit d'utiliser les produits nets pour les dépenses d'investissement, le fonds de roulement et les objectifs généraux de l'entreprise. L'offre a été réalisée conformément à une déclaration d'enregistrement sur le formulaire S-1 qui a été déclarée effective par la SEC le 31 janvier 2025.

DIH Holding US (NASDAQ: DHAI) hat erfolgreich sein zuvor angekündigtes öffentliches Angebot abgeschlossen und 4,6 Millionen Dollar an Bruttoeinnahmen erzielt. Das Angebot bestand aus 5.937.100 Einheiten, die zu einem Preis von 0,7832 Dollar pro Einheit angeboten wurden, wobei jede Einheit eine Aktie der Klasse A und einen Klasse-A-Warrant umfasst. Die Warrants sind sofort ausübbar bei 0,7832 Dollar pro Aktie und verfallen nach fünf Jahren.

Maxim Group fungierte als alleiniger Platzierungsagent für das Angebot. Das Unternehmen plant, die Nettoerlöse für Investitionen, Betriebskapital und allgemeine Unternehmenszwecke zu verwenden. Das Angebot wurde gemäß einer Registrierungsanmeldung auf dem Formular S-1 durchgeführt, die von der SEC am 31. Januar 2025 für wirksam erklärt wurde.

Positive
  • Successfully raised $4.6 million in gross proceeds
  • Warrants are immediately exercisable
  • Five-year warrant duration provides long-term financing flexibility
Negative
  • Significant dilution due to issuance of 5,937,100 new units
  • Low unit pricing at $0.7832 indicates potential market weakness
  • Additional dilution possible if warrants are exercised

Insights

The completion of DIH's $4.6 million public offering marks a significant capital event that warrants careful analysis. The offering structure reveals several key insights: First, the unit pricing at $0.7832 represents a slight premium to the current trading price, suggesting reasonable market confidence despite the dilutive nature of the raise. The inclusion of one-for-one warrants with immediate exercisability and a five-year term creates potential for additional dilution but also provides future upside participation for investors.

The offering's size, representing approximately 17.7% of the company's pre-offering market capitalization, indicates a substantial dilution for existing shareholders. However, the capital injection strengthens DIH's position in the competitive rehabilitation robotics market. The involvement of Maxim Group as sole placement agent, while ensuring deal execution, typically implies significant fees that will reduce the net proceeds available to the company.

Most critically, the stated use of proceeds for working capital and general corporate purposes suggests this raise is primarily for operational sustainability rather than specific growth initiatives. This funding pattern is common in small-cap medical device companies but raises questions about the company's path to profitability and potential need for future capital raises. The five-year warrant coverage provides a built-in mechanism for additional capital but could pressure the stock price as we approach key warrant exercise decision points.

NORWELL, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the “Company”) (NASDAQ: DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock. The Class A warrants will have an exercise price of $0.7832 per share, are exercisable immediately upon issuance, and will expire on the five-year anniversary of the original issuance date. The shares of Class A common stock and the Class A warrants comprising the units are immediately separable and were issued separately in this offering.

Maxim Group LLC acted as the sole placement agent for the offering.

The gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, were approximately $4.6 million. The Company intends to use the net proceeds from this offering for capital expenditures, working capital, and general corporate purposes.

The securities described above were offered pursuant to a registration statement on Form S-1, as amended (File No. 333-283853), which was declared effective by the Securities and Exchange Commission (the “SEC”) on January 31, 2025. The offering was made only by means of a prospectus which forms a part of the effective registration statement. A final prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus may be obtained on the SEC’s website at www.sec.gov and may also be obtained by contacting Maxim Group LLC at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus Department, or by telephone at (212) 895-3745 or by email at syndicate@maximgrp.com.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About DIH Holding US, Inc.

DIH stands for the vision to “Deliver Inspiration & Health” to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.

Caution Regarding Forward-Looking Statements

This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the services offered by DIH and the markets in which it operates, and DIH’s projected future results. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; those factors identified in our “Risk Factors” included in the Form S-1 for this offering and in our periodic filings with the SEC; the ability of DIH to achieve its projected revenue, and its continued access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

Investor Contact
Greg Chodaczek
Investor.relations@dih.com 


FAQ

How much did DIH Holding (DHAI) raise in its February 2025 public offering?

DIH Holding raised $4.6 million in gross proceeds through its public offering that closed on February 3, 2025.

What is the exercise price and expiration of DHAI's February 2025 warrants?

The Class A warrants have an exercise price of $0.7832 per share and will expire five years from their issuance date.

How many units were sold in DHAI's February 2025 public offering?

DIH Holding sold 5,937,100 units at a price of $0.7832 per unit.

What will DHAI use the proceeds from its February 2025 offering for?

DIH intends to use the net proceeds for capital expenditures, working capital, and general corporate purposes.

What was included in each unit of DHAI's February 2025 public offering?

Each unit consisted of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock.

DIH Holdings US

NASDAQ:DHAI

DHAI Rankings

DHAI Latest News

DHAI Stock Data

24.98M
17.53M
46.23%
3.44%
0.27%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NORWELL